PROCEPT BioRobotics Corporation Common Stock (PRCT) Stock
NASDAQ · PRCT
17.13
Fundamentals
Market cap
$985.11M
Price / Earnings ratio
-9.1x
Price / Sales ratio
3.0x
Price / Book ratio
3.0x
Return on assets
-20.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Business Wire
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NeutralPRCTSeptember 21, 2026
Business WireNeutral
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
PRCT

Business Wire
PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
NeutralPRCTSeptember 18, 2026
Business WireNeutral
PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
PRCT

Business Wire
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
NeutralPRCTSeptember 17, 2026
Business WireNeutral
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
PRCT

Business Wire
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation
NeutralPRCTSeptember 9, 2026
Business WireNeutral
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation
PRCT
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral3
Buy3
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
370M244M122M0
Debt & Balance Sheet
Total assets
Total liabilities
2025
610M402M201M0
Revenue to Profit
2025$308.1M
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-95.6M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Business Wire
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NeutralPRCTSeptember 21, 2026
Business WireNeutral
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
PRCT

Business Wire
PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
NeutralPRCTSeptember 18, 2026
Business WireNeutral
PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
PRCT

Business Wire
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
NeutralPRCTSeptember 17, 2026
Business WireNeutral
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
PRCT

Business Wire
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation
NeutralPRCTSeptember 9, 2026
Business WireNeutral
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation
PRCT

Business Wire
PRCT Shareholder Alert: September 22, 2026 Lead Plaintiff Deadline in PROCEPT BIOROBOTICS CORPORATION Securities Class Action - Contact Levi & Korsinsky
NeutralPRCTAugust 28, 2026
Business WireNeutral
PRCT Shareholder Alert: September 22, 2026 Lead Plaintiff Deadline in PROCEPT BIOROBOTICS CORPORATION Securities Class Action - Contact Levi & Korsinsky
PRCT

Business Wire
PRCT INVESTOR REMINDER: PROCEPT BioRobotics Corporation Investors Have Until September 22, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role
NeutralPRCTAugust 20, 2026
Business WireNeutral
PRCT INVESTOR REMINDER: PROCEPT BioRobotics Corporation Investors Have Until September 22, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role
PRCT

The Motley Fool
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?
NeutralPRCTAugust 18, 2026
The Motley FoolNeutral
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?
PRCT

Business Wire
Robbins LLP Encourages PRCT Shareholders With Significant Losses to Contact the Firm for Information About the Class Action Against PROCEPT BioRobotics Corporation
NeutralPRCTAugust 17, 2026
Business WireNeutral
Robbins LLP Encourages PRCT Shareholders With Significant Losses to Contact the Firm for Information About the Class Action Against PROCEPT BioRobotics Corporation
PRCT

Business Wire
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
NeutralPRCTAugust 12, 2026
Business WireNeutral
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
PRCT

MarketBeat
PROCEPT BioRobotics Q2 Earnings Call Highlights
NeutralPRCTAugust 5, 2026
MarketBeatNeutral
PROCEPT BioRobotics Q2 Earnings Call Highlights
PRCT
About PROCEPT BioRobotics Corporation Common Stock
No description available.
SectorHealthcare
IndustryMedical Devices
Employees888
CEOMr. Larry L. Wood
IPO DateSep 14, 2021
HeadquartersSan Jose, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Larry L. Wood | President, CEO & Director | 1966 |
| Mr. Kevin Waters | Executive VP & CFO | 1977 |
| Ms. Alaleh Nouri | EVP, Chief Legal Officer & Corporate Secretary | 1979 |
| Mr. Christofer Christoforou | Executive Vice President of Operations | 1970 |
| Mr. Barry Templin | Executive VP & CTO | — |
| Mr. Matthew James Bacso C.F.A. | Vice President of Investor Relations | — |
| Ms. Pooja Sharma Rao | Executive VP and Chief Strategy & Marketing Officer | — |
| Ms. Stacey L. Porter | Executive VP & Chief People Officer | 1975 |
| Mr. Bijesh Chandran | Executive Vice President of Regulatory Affairs & Quality Assurance | — |
| Mr. Stephen J. McGill | Senior VP & GM of International | 1962 |
Fundamentals
Valuation
Market cap$985.11M
Price-to-sales ratio2.97
Price-to-book value2.95
Price-earnings ratio-9.10
Return on Equity-28.00%
Return on Sales-34.00%
Return on Assets-20.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.94
Income Statement
Average volume1,175,430
EBITDA$-104.62M
1 year high (52w)$38.11
1 year low (52w)$16.67
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
6 Wall Street Analyst Ratings
HOLD
50% Buy
50% Hold
0% Sell
Target price
$24.20
Est return
40.78%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +1.4 | +10.2 | -23.3 | -26.1 | ||||||||
| 2022 | -26.9 | +31.8 | +34.4 | +0.3 | +5.5 | -18.7 | +22.2 | +6.0 | +2.7 | +7.1 | -6.9 | -9.5 |
| 2023 | -1.7 | -4.3 | -24.9 | -4.0 | +6.9 | +8.8 | -2.9 | +0.6 | -4.0 | -15.3 | +34.6 | +12.2 |
| 2024 | +11.7 | +2.0 | +0.7 | +12.7 | +9.6 | -6.8 | +2.3 | +27.4 | +6.7 | +18.1 | +3.6 | -16.2 |
| 2025 | -12.8 | -9.7 | -3.9 | -5.4 | +9.7 | -0.6 | -14.2 | -19.6 | -9.8 | -2.0 | -8.2 | +3.5 |
| 2026 | -5.9 | -22.1 | -3.4 | -5.2 | +6.9 | -19.0 | -20.7 | +15.3 | -17.7 |



